Professor Gerry McElvaney, RCSI University of Medicine and Health Sciences (IMAGE)

RCSI

Professor Gerry McElvaney, RCSI University of Medicine and Health Sciences

Caption

Professor Gerry McElvaney, Professor of Medicine, RCSI University of Medicine and Health Sciences and senior co-author of a new study, published in the American Journal of Respiratory and Critical Care Medicine, that has shown the survival benefit of augmentation therapy for people with the genetic lung condition AATD.

Credit

Ray Lohan/ RCSI

Usage Restrictions

None

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.